On 10 JUNE Merck & Co., Inc. (NYSE:MRK) made an official statement, revealing that it reached an agreement for the acquisition of Idenix Pharmaceuticals Inc. in a deal that is estimated to 3.85 billion dollars. The purchase will help the company to broaden its experimental pipeline for hepatitis C treatments. Merck & Co., Inc. (NYSE:MRK) net profit margin is 14.00% and weekly performance is 1.43%. On last trading day company shares ended up $58.24. Analysts mean target price for the company is $59.65. Merck & Co., Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 3.06%.
Pfizer Inc. (NYSE:PFE) announced the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass. The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and position Pfizer in closer proximity to leading academic institutions, hospitals and patient organizations. Pfizer Inc. (NYSE:PFE) shares advanced 0.27% in last trading session and ended the day on $29.53. PFE Gross Margin is 81.90% and its return on assets is 23.50%. Pfizer Inc. (NYSE:PFE) quarterly performance is -4.59%.
On 11 JUNE CONMED Corporation (NASDAQ:CNMD) reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.02. The company had revenue of $181.90 million for the quarter, compared to the consensus estimate of $191.95 million. During the same quarter in the previous year, the company posted $0.45 earnings per share. The company’s revenue for the quarter was down 2.7% on a year-over-year basis. On average, analysts predict that CONMED will post $1.94 earnings per share for the current fiscal year. CONMED Corporation (NASDAQ:CNMD) shares moved down -0.77% in last trading session and was closed at $44.04, while trading in range of $44.00 – $44.92. CONMED Corporation (NASDAQ:CNMD) year to date (YTD) performance is 4.56%.
On 14 JUNE Sanofi SA (ADR) (NYSE:SNY) and Medtronic, Inc. (NYSE: MDT) announced that they have signed a memorandum of understanding to enter into a global strategic alliance in diabetes, aimed at improving patient experience and outcomes for people with diabetes around the world. Sanofi SA (ADR) (NYSE:SNY) ended the last trading day at $53.78. Company weekly volatility is calculated as 0.63% and price to cash ratio as 25.21. Sanofi SA (ADR) (NYSE:SNY) showed a negative weekly performance of -0.59%.
Roche Holding Ltd. (ADR) (OTCMKTS: RHHBY) on last trading day company shares ended up $36.93.
Leave a Reply